4//SEC Filing
Zeronda Tyler 4
Accession 0001209191-23-022806
CIK 0001566044other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:07 PM ET
Size
5.4 KB
Accession
0001209191-23-022806
Insider Transaction Report
Form 4
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2023-03-31$3.08/sh−384$1,183→ 8,108 total
Footnotes (2)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
- [F2]On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001867033
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:07 PM ET
- Size
- 5.4 KB